BlackRock’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Sell
35,903
-452
-1% -$2.96K ﹤0.01% 4723
2025
Q4
$210K Hold
36,355
﹤0.01% 4712
2025
Q3
$159K Buy
+36,355
New +$158K ﹤0.01% 4729
2025
Q2
Sell
-8,324
Closed -$47.9K 5593
2025
Q1
$47.9K Buy
8,324
+1,097
+15% +$6.69K ﹤0.01% 4927
2024
Q4
$57.4K Buy
7,227
+45
+0.6% +$249 ﹤0.01% 4911
2024
Q3
$29.3K Buy
7,182
+1,998
+39% +$8.02K ﹤0.01% 4894
2024
Q2
$26K Buy
+5,184
New +$51K ﹤0.01% 4970
2022
Q2
Sell
-2,417
Closed -$31K 5993
2022
Q1
$31K Buy
2,417
+812
+51% +$11.9K ﹤0.01% 5503
2021
Q4
$33K Buy
1,605
+461
+40% +$11.5K ﹤0.01% 5475
2021
Q3
$33K Buy
+1,144
New +$32.8K ﹤0.01% 5343

Other funds holding UNCY